Charsire Biotechnology Corp.

Quick facts

Phase 2 pipeline

• BAC treatment · Cardiovascular
  BAC treatment works by inhibiting the activity of a specific enzyme.
• CSTC1

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Charsire Biotechnology Corp. portfolio CI brief
• Charsire Biotechnology Corp. pipeline updates RSS

Related

• Sector hub: All tracked pharma companies